Cargando…

17β-estradiol and methylation of migraine-related genes

Detalles Bibliográficos
Autores principales:	Labruijere, S, Verbiest, M, De Vries, R, Danser, AHJ, Uitterlinden, AG, Stolk, L, MaassenVanDenBrink, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620343/ http://dx.doi.org/10.1186/1129-2377-14-S1-P29

Ejemplares similares

Measurements of 17β-estradiol levels in mice for migraine research
por: Chan, K, et al.
Publicado: (2013)

Endothelin-converting-enzyme 1 inhibition and CGRP receptor recycling in human coronary and middle meningeal arteries
por: Labruijere, S, et al.
Publicado: (2013)

Sumatriptan and dihydroergotamine in proximal and distal human isolated coronary arteries
por: Labruijere, S, et al.
Publicado: (2013)

Methylation of Migraine-Related Genes in Different Tissues of the Rat
por: Labruijere, Sieneke, et al.
Publicado: (2014)

Influence of varying estrogen levels on trigeminal CGRP release in healthy women
por: Ibrahimi, K, et al.
Publicado: (2013)

Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds
por: Grände, Gustaf, et al.
Publicado: (2014)

Serum CGRP in migraine patients using erenumab as preventive treatment
por: de Vries Lentsch, Simone, et al.
Publicado: (2022)

Headache medication and the COVID-19 pandemic
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2020)

Trigeminovascular calcitonin gene-related peptide function in Cacna1a R192Q-mutated knock-in mice
por: Chan, Kayi Y, et al.
Publicado: (2017)

Capsaicin-induced CGRP-mediated vasodilatation of the human skin: influence of gender, female hormones and migraine
por: Vermeersch, SGG, et al.
Publicado: (2013)

The potential danger of blocking CGRP for treating migraine in CADASIL patients
por: de Boer, Irene, et al.
Publicado: (2020)

Gender aspects of CGRP in migraine
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017)

Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2018)

EHMTI-0096. Efficacy of sumatriptan: assessment of a possible biomarker
por: Ibrahimi, K, et al.
Publicado: (2014)

Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus
por: Rivera-Mancilla, Eduardo, et al.
Publicado: (2021)

Revisiting dose-finding of monoclonal antibodies in migraine
por: Al-Hassany, Linda, et al.
Publicado: (2023)

Pain perception in women with menstrually-related migraine
por: Linstra, Katie M, et al.
Publicado: (2020)

Blocking the CGRP Receptor: Differences across Human Vascular Beds
por: de Vries, Tessa, et al.
Publicado: (2023)

Jealousy in women with migraine: a cross-sectional case-control study
por: van Casteren, Daphne S., et al.
Publicado: (2020)

Characterization of the trigeminovascular actions of several adenosine A(2A) receptor antagonists in an in vivo rat model of migraine
por: Haanes, Kristian A., et al.
Publicado: (2018)

Anti‐migraine Calcitonin Gene–Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice
por: Mulder, Inge A., et al.
Publicado: (2020)

Sex differences in prevalence of migraine trigger factors: A cross-sectional study
por: van Casteren, Daphne S, et al.
Publicado: (2020)

Validation of diagnostic ICHD-3 criteria for menstrual migraine
por: Verhagen, Iris E, et al.
Publicado: (2022)

Migraine in neurological department of fann teaching hospital in Dakar
por: Seck, LB, et al.
Publicado: (2013)

Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study
por: Verhagen, Iris E., et al.
Publicado: (2021)

Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary
por: van Casteren, Daphne S., et al.
Publicado: (2021)

Correction to: Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study
por: Verhagen, Iris E., et al.
Publicado: (2021)

Could erectile dysfunction be a side effect of CGRP inhibition? A case report
por: Al-Hassany, Linda, et al.
Publicado: (2021)

The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse
por: van Hoogstraten, Willem Sebastiaan, et al.
Publicado: (2019)

Analysis of subjects with menstrually related migraine vs. Non-menstrually related migraine treated with MAP0004
por: Aurora, S, et al.
Publicado: (2013)

Migraine without aura: genome-wide association analysis identifies several novel susceptibility
por: De Vries, B Loci, et al.
Publicado: (2013)

Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2021)

Estradiol cypionate modulates immunological response during sepsis
por: da Silva, Luiz E, et al.
Publicado: (2013)

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021)

Survey of the differences between Migraine and MOH pre-existing migraine
por: Igarashi, H
Publicado: (2013)

Comment on “A second trigeminal CGRP receptor: function and expression of the AMY1 receptor”
por: Haanes, Kristian Agmund, et al.
Publicado: (2016)

Migraine without aura: genome-wide association analysis identifies several novel susceptibility
por: de Vries, Boukje, et al.
Publicado: (2013)

In vitro inhibition of porcine cytochrome P450 by 17β -estradiol and 17α-estradiol
por: Zamaratskaia, Galia, et al.
Publicado: (2011)

P-selectin, an important mediator of angiogenesis in females: the role of estradiol
por: Koch, AE, et al.
Publicado: (2004)

Association between night shift work, melatonin and estradiol in nurses
por: Peplonska, Beata, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ifnfmemkk6a219nese2g79dl5h